解郁合欢汤联合调Q激光治疗肝郁气滞型黄褐斑临床观察
Efficacy observation of Jieyu Hehuan decoction and Q-switched laser on chloasma with syndrome of stagnation of qi due to depression of the live
魏甲丽 1贺琪2
作者信息
- 1. 湖北中医药大学中医学院(武汉430065)
- 2. 湖北中医药大学附属湖北省中医院
- 折叠
摘要
目的:观察解郁合欢汤联合调Q Nd:YAG激光治疗肝郁气滞型黄褐斑的临床疗效和安全性.方法:选取符合纳入标准的黄褐斑患者60例,采用随机数字表法分为两组各30例.对照组予调Q Nd:YAG激光治疗,治疗组在对照组基础上予解郁合欢汤.治疗3个月,观察两组患者黄褐斑面积和严重指数(MASI)评分、黄褐斑皮损疗效及不良反应情况.结果:治疗后,治疗组黄褐斑皮损疗效指数为83.33％明显高于对照组的63.33％,差异具有统计学意义(P＜0.05);两组患者MASI评分均较治疗前降低,且治疗组评分低于对照组,差异具有统计学意义(P＜0.05).结论:在调Q Nd:YAG激光治疗的基础上联合解郁合欢汤方治疗肝郁气滞型黄褐斑临床疗效较好.
Abstract
Objective:To observe the clinical efficacy and safety of Jieyu Hehuan decoction and Q-switched Nd:YAG laser on chloasma with syndrome of stagnation of qi due to depression of the live.Methods:60 cases of eligible patients with chloasma were selected and randomly divided into two groups,30 cases in each group.The control group was treated by Q-switched Nd:YAG laser,while the treatment group was treated plus with Jieyu Hehuan decoction on the basis of control group.After 3 months of treatment,the scores of melasma area severity index(MASI),the evaluation criteria of curative efficacy on chloasma skin lesion and the adverse reactions were observed in two groups of patients.Results:After treatment,the index of curative efficacy on chloasma skin lesion in the treatment group was 83.33％,which was significantly higher than 63.33％in the control group,and the difference was statistically significant(P＜0.05);MASI scores of patients in both groups were lower than before treatment,and the score of treatment group was lower than that of control group,and the difference was statistically significant(P＜0.05).Conclusion:On the basis of treatment by Q-switched Nd:YAG laser,the clinical efficacy of combined Jieyu Hehuan decoction on chloasma with syndrome of stagnation of qi due to depression of the live is better.
关键词
黄褐斑/肝郁气滞/解郁合欢汤/中医药疗法Key words
chloasma/syndrome of stagnation of qi due to depression of the live/Jieyu Hehuan decoction/therapy of TCM引用本文复制引用
出版年
2024
NETL
NSTL
维普
万方数据